openPR Logo
Press release

MERCIAN LABELS LAUNCHES ANTI MICROBIAL LABELS TO LIMIT MSRA SPREAD IN HOSPITALS

04-02-2007 03:16 PM CET | Health & Medicine

Press release from: Mercian Labels

Mercian Labels has launched a new range of anti microbial self adhesive labels to combat the spread of hospital acquired infections such as MRSA.

The new labelling range uses TenzaGuardÔ to inhibit the growth and spread of bacteria on labels, allowing optimal hygiene conditions to be preserved. Labels are currently used in many different hospital and pharmaceutical labelling applications where bacteria can easily contaminate and spread from surface to surface. The new range of anti microbial labels include active ingredients in the anti-microbial face material that are 99.9% effective in limiting the growth of MRSA, C-Diff, Listeria, E-Coli, Salmonella and a range of other harmful bacteria.

The active ingredient is inorganic (silver, a proven anti microbial) and bacteria are highly unlikely to become immune to the product. It is also harmless to humans and animals and safe to use in all environments. Extensive testing has shown that the effectiveness of the coating does not diminish significantly with time or handling, meaning that the labels will retain their anti microbial properties for the life of the label itself.

Dr Adrian Steele, Managing Director of Mercian Labels believes that anti microbial labels are a highly cost-effective solution to the spread of hospital borne infections. “There is now a proven solution to anti microbial labelling, giving peace of mind to organisations responsible for labelling of medical devices and consumables. This is another proven tool in the battle to beat the spread of hospital borne inflections”

Further details of the product range can be obtained at http://www.selfadhesivelabels.com/anti-microbial-labels.html

Mercian Labels Ltd are the UK’s specialists in anti microbial labels http://www.selfadhesivelabels.com/anti-microbial-labels.html

For further information please contact adrian@selfadhesivelabels.com
Mercian Labels Ltd, Watling Street, Cannock, WS11 0BD, UK 44 870 060 6491 www.selfadhesivelabels.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release MERCIAN LABELS LAUNCHES ANTI MICROBIAL LABELS TO LIMIT MSRA SPREAD IN HOSPITALS here

News-ID: 17789 • Views:

More Releases for MRSA

Mrsa Drugs Market Size, Share, Forecast Report 2025-2034
The MRSA Drugs Market Is Set To Grow At An Estimated CAGR Of 6.5% From 2025 To 2034, Rising From $6.8 Billion In 2024 To $11 Billion By 2034. On April 29, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Mrsa Drugs market goods. The market study excludes key regions that are accelerating marketization. This section
Combating MRSA with Cutting-Edge Pharmaceutical Advances
"The Business Research Company recently released a comprehensive report on the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The methicillin-resistant
MRSA Antibiotics Market Analysis, Size, Current Scenario and Future Prospects
MRSA Antibiotics Market was estimated at US$ billion in 2023 and is predicted to reach US$ billion by 2029 with sales revenue expected to register CAGR of 4.3% over the forecast period. Rising number of surgical conditions from chronic diseases such as diabetes, chronic respiratory and renal diseases are expected to increase the demand of post-operative MRSA anti-infective therapies. Important changes in the business allow key players to attain larger profits.
VRE and MRSA Antibiotic Market 2021 | Detailed Report
According to Market Study Report, VRE and MRSA Antibiotic Market provides a comprehensive analysis of the VRE and MRSA Antibiotic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of VRE and MRSA Antibiotic Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4645656 The
MRSA Testing Market Analysis of Top industry Scenario
Global MRSA Testing Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Global MRSA Testing Market by Type (Immunodiagnostics and Molecular Diagnostics) By
Find out Why MRSA Antibiotics Market Is Thriving Worldwide
A new market study on Global (United States, European Union and China) MRSA Antibiotics Market with 100+ market data Tables, Pie Chart & Graphs is released that will provide complete assessment of the Market and covers evolving trends, current scenario analysis and growth factors, and industry validated market data. The research study provides market breakdown by revenue and volume (if applicable) and price history estimates for Global (United States, European